.png){kind=icon}
.png){kind=icon}
Return
Clinical and Laboratory Transition Between GPA and EGPA
.png){kind=icon}
OA
AI
S
M
C
S
N
S
M
N
P
DOI：10.1016/j.chest.2026.03.039.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA) are recognized subtypes of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Their clinical boundaries, however, may be more dynamic than assumed. We describe 2 patients illustrating sequential phenotype transitions with prominent respiratory involvement. The first patient was initially diagnosed with GPA, presenting with neuropathy, purpura, epistaxis, renal disease, and myeloperoxidase (MPO)-ANCA positivity. Six years later, she developed asthma, marked eosinophilia, and eosinophilic myocarditis, consistent with evolution toward EGPA despite stable ANCA serology. The second patient was first classified as EGPA based on eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and MPO-ANCA with borderline proteinase 3 (PR3)-ANCA. After SARS-CoV-2 infection, he developed GPA-like disease with strongly positive PR3-ANCA and destructive airway involvement, including tracheobronchomalacia requiring tracheostomy and stenting. These cases highlight that recognizing this dynamic nature is essential for the timely reassessment of disease classification, prognosis, and therapeutic approach in AAV.
Keywords:
ANCA-associated vasculitis
granulomatosis with polyangiitis
eosinophilic granulomatosis with polyangiitis
MPO-ANCA
PR3-ANCA
tracheobronchomalacia
AAV
ANCA-associated vasculitis
ANCA
antineutrophil cytoplasmic antibody
BAFF
B-cell activating factor
EGPA
eosinophilic granulomatosis with polyangiitis
GINA
Global Initiative for Asthma
GPA
granulomatosis with polyangiitis
MPO
myeloperoxidase
PR3
proteinase 3
TNF- α
tumor necrosis factor alpha
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
8.6
Papers:
4.9W
Citations:
5.1W
Organization
No organization information available
Cited Papers